Andrew McLean

James Cook University Hospital

Papers

2

Total Citations

97

H-Index

2

About

Andrew McLean is a urological surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for prostate and kidney cancers. His major contributions lie in evidence-based comparisons of robotic-assisted procedures, particularly through systematic reviews and meta-analyses that guide clinical decision-making. McLean’s most cited paper, a 2019 meta-analysis comparing Retzius-sparing versus conventional robotic-assisted radical prostatectomy (66 citations), has helped clarify the benefits of preserving anatomical structures to improve functional outcomes. He also conducted a pivotal systematic review on trans-peritoneal versus retroperitoneal robotic partial nephrectomy for posterior renal tumors (31 citations), advocating for a risk-stratified, patient-individualized approach. Beyond these landmark studies, McLean’s work emphasizes the need for tailored surgical strategies, balancing oncologic control with quality of life. His research has been instrumental in shaping modern urological practice, offering surgeons and patients clearer evidence for choosing between competing techniques. With a focus on rigorous methodology and clinical relevance, McLean continues to influence the field of robotic urology, making his contributions essential reading for trainees and specialists alike.

Research Focus

Key Achievements

2
H-Index
2
Papers
97
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis
66 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: James Cook University Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago